[HTML][HTML] Alteration of the esophageal microbiota in Barrett's esophagus and esophageal adenocarcinoma
J Lv, L Guo, JJ Liu, HP Zhao, J Zhang… - World journal of …, 2019 - ncbi.nlm.nih.gov
The incidence of esophageal adenocarcinoma (EAC) has increased in recent decades, and
its 5-year survival rate is less than 20%. As a well-established precursor, patients with …
its 5-year survival rate is less than 20%. As a well-established precursor, patients with …
Safety and tolerability of immune checkpoint inhibitors (PD-1 and PD-L1) in cancer
I Baraibar, I Melero, M Ponz-Sarvise, E Castanon - Drug safety, 2019 - Springer
Immunotherapy has emerged in recent years and has revolutionized the treatment of cancer.
Immune checkpoint inhibitors, including anti-cytotoxic T lymphocyte antigen-4 (CTLA-4), anti …
Immune checkpoint inhibitors, including anti-cytotoxic T lymphocyte antigen-4 (CTLA-4), anti …
Incidence of pancreatitis with the use of immune checkpoint inhibitors (ICI) in advanced cancers: a systematic review and meta-analysis
Background Systemic immune side effects including pancreatitis have been reported with
the use of Immune Checkpoint Inhibitors (ICI)(CTLA-4, PD-1 and PDL-1). However, the true …
the use of Immune Checkpoint Inhibitors (ICI)(CTLA-4, PD-1 and PDL-1). However, the true …
Management of immune related adverse events induced by immune checkpoint inhibition
In recent years, immune checkpoint inhibitors (ICIs) were successfully introduced to cancer
therapy and these drugs have already become essential for the treatment of various non …
therapy and these drugs have already become essential for the treatment of various non …
Clinical Significance of Signs of Autoimmune Colitis in 18F-Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography of 100 Stage-IV Melanoma …
N Lang, J Dick, A Slynko, C Schulz… - …, 2019 - Taylor & Francis
Aim: Autoimmune colitis is a typical and possible severe side effect among patients treated
with ipilimumab. Patients & methods: We prospectively included 100 patients with …
with ipilimumab. Patients & methods: We prospectively included 100 patients with …
Frequency and imaging features of abdominal immune-related adverse events in metastatic lung cancer patients treated with PD-1 inhibitor
F Alessandrino, S Sahu, M Nishino, AE Adeni… - Abdominal …, 2019 - Springer
Purpose To investigate the frequency and imaging features of radiographically evident
abdominal immune-related adverse events (irAEs) in patients with metastatic non-small-cell …
abdominal immune-related adverse events (irAEs) in patients with metastatic non-small-cell …
Immune-related pancreatitis associated with checkpoint blockade in melanoma
J Kohlmann, D Wagenknecht, JC Simon… - Melanoma …, 2019 - journals.lww.com
Recognizing and treating rare checkpoint inhibitor related adverse events may be a clinical
challenge in melanoma therapy. One of rather rare affected organs is the pancreas. Immune …
challenge in melanoma therapy. One of rather rare affected organs is the pancreas. Immune …
Focal immunotherapy-induced pancreatitis mimicking metastasis on FDG PET/CT
JP Das, D Halpenny, RK Do… - Clinical Nuclear Medicine, 2019 - journals.lww.com
A 46-year-old man with metastatic lung adenocarcinoma was treated with pembrolizumab.
FDG PET/CT was performed after 3 cycles of treatment and revealed a focal region of …
FDG PET/CT was performed after 3 cycles of treatment and revealed a focal region of …
18F-FDG PET/CT of Multiorgan Sarcoid-Like Reaction During Anti–PD-1 Treatment for Melanoma
WW van Willigen, WR Gerritsen… - Clinical Nuclear …, 2019 - journals.lww.com
We report a case of a 50-year-old woman treated with anti–PD-1 inhibition for metastatic
melanoma. During treatment, extensive and transient histopathologically confirmed sarcoid …
melanoma. During treatment, extensive and transient histopathologically confirmed sarcoid …